Developer docs
API playgroundTry for free, no card

Search company profiles

curing retinal blindness foundation

Full company profile

uuid02mfmnz

Namestring
curing retinal blindness foundation
Legal namestring
Curing Retinal Blindness Foundation
Websiteurl
crb1.org
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Curing Retinal Blindness Foundation (CRBF) is a 501(c)(3) nonprofit organization founded in 2011 by Mike and Kristin Smedley, headquartered in Salem, Ohio, and originating from Bucks County, Pennsylvania. It is the only patient organization specifically dedicated to CRB1 retinal disease, a rare genetic condition causing Leber's Congenital Amaurosis (LCA), Retinitis Pigmentosa (RP), and cone-rod dystrophy, affecting approximately 80,000 people worldwide. The foundation's core mission is to fund research for treatments and cures while connecting affected families to resources for thriving without sight.

CRBF's operational products include a website platform (crb1.org) built by Advanta Advertising, a CRB1 Patient Registry that collects structured data on affected individuals to support research, the "Clearly Seeing Blind" youth-advocate blog, and a main CRBF blog for community updates. It also operates multiple fundraising campaigns — Eye on the Finish Line, Cars for the Cure, Drive the Research, and the Light the Night Cocktails for a Cure signature event — alongside the R.B. EYE September Slam annual softball tournament. Programmatic assets include a Grant Application Program for researchers, resources for raising blind/visually impaired children, and event-hosting tools for community fundraising. The foundation funds five active research projects worldwide and supported the securing of a $1.25 million NIH grant through Dr. Pete Quinn in 2023.

The organization's business model is entirely donation-driven: it raises funds through individual contributions, fundraising events, and partnerships with rare disease organizations (NORD), trade associations (Life Sciences PA), and pharmaceutical companies (Novartis awareness presentation). It does not sell products or services, has no disclosed employees beyond its co-founder/leadership, and has cumulatively raised over $1.4 million since launch. Distribution is global through its website, social media (Instagram), family meetups across the US East Coast, Midwest, and West Coast, and international meetups in Spain and the UK, supplemented by attendance at industry events such as the BIO International Convention.

Short descriptiontext

Curing Retinal Blindness Foundation (CRBF) is a 501(c)(3) nonprofit, founded in 2011 and based in Salem, Ohio, that is the only patient organization dedicated to CRB1 retinal disease (LCA/RP), funding research, maintaining a patient registry, and connecting the ~80,000 affected families globally to support resources.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSalem, United States
HQ citystring
Salem
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease research funding, retinal disease advocacy, patient registry services, nonprofit foundation grants, blindness support resources
Industry2 codes
PRIMARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
Product category
Nonprofit Disease Advocacy Foundation
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Fundraising
TypeAffiliate Referral
Description

CRBF raises funds through donations, fundraising events, and campaigns. The foundation receives contributions from individual donors, families, and organizations to fund CRB1 retinal disease research projects.

crb1.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Others, Personnel, Marketing or Sales, Operations
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 5 records shown
1Clearly Seeing Blind
Description

Blog written by youth patient advocates of the Curing Retinal Blindness Foundation, providing a platform for sharing experiences of living with blindness.

crb1.org
+4 more records
Core offering1 text field

CRBF is a 501(c)(3) nonprofit foundation that funds scientific research toward treatments and cures for CRB1 retinal disease (Leber's Congenital Amaurosis, Retinitis Pigmentosa, and cone-rod dystrophy). It maintains a CRB1 Patient Registry to support research efforts, connects affected families with resources for thriving with blindness, and runs awareness and fundraising campaigns including Eye on the Finish Line, Cars for the Cure, and Drive the Research.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • $1.4 million raised for CRB1 research
+2 more records
Product overview1 text field

The Curing Retinal Blindness Foundation operates primarily as a non-profit advocacy organization rather than a technology company. Its core offering is a comprehensive website platform that serves as the central hub for its mission to support children and adults blind or visually impaired due to CRB1 retinal disease. The platform includes a CRB1 Patient Registry for connecting patients with research, the Clearly Seeing Blind Blog written by youth patient advocates, and the CRBF Blog for general updates. The foundation also runs multiple fundraising campaigns including Eye on the Finish Line, Cars for the Cure, and Drive the Research, along with event hosting tools for community fundraising activities. Resources for families provide educational materials about assistive technology and living with blindness, while the Grant Application Program supports researchers working on CRB1 treatments.

Product and service6 records
1CRB1 Patient Registry
CategoryResearch Support / Data Registry
Description

A patient registry that collects and maintains data on individuals affected by CRB1 retinal disease to support research efforts and connect patients with research opportunities and clinical resources.

2Research Grant Program
CategoryResearch Funding / Grant Program
Description

A program offering research grant opportunities for scientists and researchers studying CRB1 retinal disease, funding projects including natural history studies, biomarker development, and gene therapy research for CRB1 mutations.

3Eye on the Finish Line Campaign
CategoryFundraising Campaign
Description

A fundraising campaign focused on raising awareness and funds to drive CRB1 research toward finding a cure for the disease.

4Drive the Research
CategoryAwareness / Fundraising Campaign
Description

A fundraising and awareness campaign featuring the Smedley family's story about CRB1 blindness, including awareness videos to drive research funding.

5Cars for the Cure
CategoryFundraising Campaign
Description

A fundraising initiative within the foundation's campaign portfolio supporting CRB1 research through automobile-related events.

6Family Resources for Living with Blindness
CategoryFamily Support Services
Description

Educational and support resources for families affected by CRB1 retinal disease, including tools for the blind and visually impaired, assistive technology guides, and FAQs about CRB1 diagnosis and care.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Life Sciences PA, the only life sciences trade association in Pennsylvania, hosted a pavilion at BIO 2019 where CRBF President Kristin Smedley held meetings and connected with rare disease advocacy colleagues.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2019-01-01
Description

Advanta is identified as the company that created the CRBF website. They are a life sciences branding and marketing company that met with Kristin Smedley at BIO 2019 to discuss spreading the foundation's mission.

3R.B. EYE September Slam
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2013-01-01
Description

Annual softball tournament, auction, and picnic fundraising event created by the Billingsley family in St. Paul, Missouri, benefiting CRBF. Has raised over $110,000.

crb1.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CRBF presented at Novartis Pharmaceutical in Boston to educate about living with blindness. Novartis owns rights to Luxturna (gene therapy for LCA-RPE65) outside the United States. The presentation aimed to build relationships for potential CRB1 research collaboration.

5ShadowBox Pictures
Strategic tierMinorTypeGTM or Marketing Partner
Description

ShadowBox Pictures of Yardley, PA produced an awareness video for CRBF starring the Smedley family, featuring their blind son Michael to raise awareness about CRB1 retinal disease.

crb1.org
6DeAngelo Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The DeAngelo Foundation is mentioned in connection with Pennsylvania-based doctors and research. The Biggs family connected with CRBF through their local doctor and the DeAngelo Foundation.

crb1.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CRBF is planning family meetups in tandem with NORD's annual summit at the Rock and Roll Hall of Fame in Cleveland, Ohio. This partnership provides access to the broader rare disease community.

8Dr. Pete Quinn (Uplifting Athletes)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Pete Quinn received the Uplifting Athletes Young Investigator award and has helped secure a $1.25 million NIH grant for CRB1 research.

crb1.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The Choroideremia Research Foundation funds research into a rare inherited retinal disorder and provides education, support, and community connections for affected families. It is a direct disease-specific peer to CRBF's CRB1 research-funding and family-support model.

TypeBroad incumbent
Description

Foundation Fighting Blindness is a larger nonprofit that funds research into inherited retinal diseases and supports patients and families. Its broader retinal-disease portfolio overlaps CRBF's mission and provides a relevant scale and operating-model benchmark.

TypeDirect peer
Description

The Usher Syndrome Coalition is a patient-led nonprofit advancing research, education, and support for Usher syndrome, a rare genetic condition involving vision and hearing loss. Its patient-community and research-advocacy model closely parallels CRBF's.

4Retina International
TypeBroad incumbent
Description

Retina International is a global umbrella organization representing people with retinal dystrophies and promoting research and access to care. It is comparable as a broader retinal-disease advocacy and research platform.

TypeDirect peer
Description

The Vision of Children Foundation funds research and family support for children with genetic vision disorders. It is directly comparable in combining a rare genetic eye-disease mission, research grants, and affected-family support.

TypeBroad incumbent
Description

Fight for Sight is a UK-based charity that funds vision and eye research and mobilizes donors around sight loss. It is a relevant research-funder peer, although it is not focused specifically on CRB1 or operating a patient registry.

7Fighting Blindness Canada
TypeRegional player
Description

Fighting Blindness Canada is a Canadian nonprofit supporting people affected by inherited retinal disease and funding vision research. It is a regional peer with similar patient education, advocacy, and research-funding activities.

TypeRegional player
Description

Macular Disease Foundation Australia is a national patient organization providing macular-disease education, support, and research advocacy. It is a regional peer because it shares a disease-specific eye-support model but serves Australia.

TypeBroad incumbent
Description

The National Organization for Rare Disorders is a broad U.S. rare-disease organization that supports patient groups, research, and advocacy. CRBF's relationship and meetup plans with NORD make it an ecosystem-level peer despite its broader disease scope.

TypeBroad incumbent
Description

Global Genes is a rare-disease patient advocacy and education organization that connects patients, advocates, and industry. It is a broad ecosystem peer rather than a direct CRB1 competitor.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

curing retinal blindness foundation

Nonprofit Disease Advocacy Foundationcrb1.org

Curing Retinal Blindness Foundation (CRBF) is a 501(c)(3) nonprofit, founded in 2011 and based in Salem, Ohio, that is the only patient organization dedicated to CRB1 retinal disease (LCA/RP), funding research, maintaining a patient registry, and connecting the ~80,000 affected families globally to support resources.

What curing retinal blindness foundation does

Curing Retinal Blindness Foundation (CRBF) is a 501(c)(3) nonprofit organization founded in 2011 by Mike and Kristin Smedley, headquartered in Salem, Ohio, and originating from Bucks County, Pennsylvania. It is the only patient organization specifically dedicated to CRB1 retinal disease, a rare genetic condition causing Leber's Congenital Amaurosis (LCA), Retinitis Pigmentosa (RP), and cone-rod dystrophy, affecting approximately 80,000 people worldwide. The foundation's core mission is to fund research for treatments and cures while connecting affected families to resources for thriving without sight.

CRBF's operational products include a website platform (crb1.org) built by Advanta Advertising, a CRB1 Patient Registry that collects structured data on affected individuals to support research, the "Clearly Seeing Blind" youth-advocate blog, and a main CRBF blog for community updates. It also operates multiple fundraising campaigns — Eye on the Finish Line, Cars for the Cure, Drive the Research, and the Light the Night Cocktails for a Cure signature event — alongside the R.B. EYE September Slam annual softball tournament. Programmatic assets include a Grant Application Program for researchers, resources for raising blind/visually impaired children, and event-hosting tools for community fundraising. The foundation funds five active research projects worldwide and supported the securing of a $1.25 million NIH grant through Dr. Pete Quinn in 2023.

The organization's business model is entirely donation-driven: it raises funds through individual contributions, fundraising events, and partnerships with rare disease organizations (NORD), trade associations (Life Sciences PA), and pharmaceutical companies (Novartis awareness presentation). It does not sell products or services, has no disclosed employees beyond its co-founder/leadership, and has cumulatively raised over $1.4 million since launch. Distribution is global through its website, social media (Instagram), family meetups across the US East Coast, Midwest, and West Coast, and international meetups in Spain and the UK, supplemented by attendance at industry events such as the BIO International Convention.

curing retinal blindness foundation firmographics

Firmographics
Name
curing retinal blindness foundation
Legal name
Curing Retinal Blindness Foundation
Website
https://crb1.org
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1–10 employees
Short description
Curing Retinal Blindness Foundation (CRBF) is a 501(c)(3) nonprofit, founded in 2011 and based in Salem, Ohio, that is the only patient organization dedicated to CRB1 retinal disease (LCA/RP), funding research, maintaining a patient registry, and connecting the ~80,000 affected families globally to support resources.
Ownership category
akta.pro rank

curing retinal blindness foundation industry classification

Industry
Product category
Nonprofit Disease Advocacy Foundation
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
akta.pro industry
PRIMARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs

Keywords

  • Rare disease research funding
  • Retinal disease advocacy
  • Patient registry services
  • Nonprofit foundation grants
  • Blindness support resources

Where curing retinal blindness foundation is headquartered

Location

Headquarters

HQ city
Salem
HQ country
United States
HQ region
North America

Offices1 record

Markets served

curing retinal blindness foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Others, Personnel, Marketing or Sales, Operations

Revenue model

  1. Donations and Fundraising: CRBF raises funds through donations, fundraising events, and campaigns. The foundation receives contributions from individual donors, families, and organizations to fund CRB1 retinal disease research projects.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

curing retinal blindness foundation product offering

Product offering

Core offering

CRBF is a 501(c)(3) nonprofit foundation that funds scientific research toward treatments and cures for CRB1 retinal disease (Leber's Congenital Amaurosis, Retinitis Pigmentosa, and cone-rod dystrophy). It maintains a CRB1 Patient Registry to support research efforts, connects affected families with resources for thriving with blindness, and runs awareness and fundraising campaigns including Eye on the Finish Line, Cars for the Cure, and Drive the Research.

Product overview

The Curing Retinal Blindness Foundation operates primarily as a non-profit advocacy organization rather than a technology company. Its core offering is a comprehensive website platform that serves as the central hub for its mission to support children and adults blind or visually impaired due to CRB1 retinal disease. The platform includes a CRB1 Patient Registry for connecting patients with research, the Clearly Seeing Blind Blog written by youth patient advocates, and the CRBF Blog for general updates. The foundation also runs multiple fundraising campaigns including Eye on the Finish Line, Cars for the Cure, and Drive the Research, along with event hosting tools for community fundraising activities. Resources for families provide educational materials about assistive technology and living with blindness, while the Grant Application Program supports researchers working on CRB1 treatments.

Differentiator

Problem solved

Functional benefit

Brands

  • Clearly Seeing Blind: Blog written by youth patient advocates of the Curing Retinal Blindness Foundation, providing a platform for sharing experiences of living with blindness.
  • Eye on the Finish Line Campaign
  • Cars for the Cure
  • Drive the Research
  • Light the Night, Cocktails for a Cure

Products and services

  • CRB1 Patient Registry A patient registry that collects and maintains data on individuals affected by CRB1 retinal disease to support research efforts and connect patients with research opportunities and clinical resources.
  • Research Grant Program A program offering research grant opportunities for scientists and researchers studying CRB1 retinal disease, funding projects including natural history studies, biomarker development, and gene therapy research for CRB1 mutations.
  • Eye on the Finish Line Campaign A fundraising campaign focused on raising awareness and funds to drive CRB1 research toward finding a cure for the disease.
  • Drive the Research A fundraising and awareness campaign featuring the Smedley family's story about CRB1 blindness, including awareness videos to drive research funding.
  • Cars for the Cure A fundraising initiative within the foundation's campaign portfolio supporting CRB1 research through automobile-related events.
  • Family Resources for Living with Blindness Educational and support resources for families affected by CRB1 retinal disease, including tools for the blind and visually impaired, assistive technology guides, and FAQs about CRB1 diagnosis and care.

Quantifiable outcome

  • $1.4 million raised for CRB1 research
  • +2 more outcomes

Companies that use curing retinal blindness foundation

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

curing retinal blindness foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

curing retinal blindness foundation partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Life Sciences PAcoreStrategic or Co-development Partner · 1 January 2019Life Sciences PA, the only life sciences trade association in Pennsylvania, hosted a pavilion at BIO 2019 where CRBF President Kristin Smedley held meetings and connected with rare disease advocacy colleagues.
  • Advanta Advertising, LLCminorImplementation/ SI/ Consulting Partner · 1 January 2019Advanta is identified as the company that created the CRBF website. They are a life sciences branding and marketing company that met with Kristin Smedley at BIO 2019 to discuss spreading the foundation's mission.
  • R.B. EYE September SlamminorGTM or Marketing Partner · 1 January 2013Annual softball tournament, auction, and picnic fundraising event created by the Billingsley family in St. Paul, Missouri, benefiting CRBF. Has raised over $110,000.
  • Novartis PharmaceuticalcoreStrategic or Co-development PartnerCRBF presented at Novartis Pharmaceutical in Boston to educate about living with blindness. Novartis owns rights to Luxturna (gene therapy for LCA-RPE65) outside the United States. The presentation aimed to build relationships for potential CRB1 research collaboration.
  • ShadowBox PicturesminorGTM or Marketing PartnerShadowBox Pictures of Yardley, PA produced an awareness video for CRBF starring the Smedley family, featuring their blind son Michael to raise awareness about CRB1 retinal disease.
  • DeAngelo FoundationcoreStrategic or Co-development PartnerThe DeAngelo Foundation is mentioned in connection with Pennsylvania-based doctors and research. The Biggs family connected with CRBF through their local doctor and the DeAngelo Foundation.
  • National Organization for Rare Disorders (NORD)coreStrategic or Co-development PartnerCRBF is planning family meetups in tandem with NORD's annual summit at the Rock and Roll Hall of Fame in Cleveland, Ohio. This partnership provides access to the broader rare disease community.
  • Dr. Pete Quinn (Uplifting Athletes)coreStrategic or Co-development PartnerDr. Pete Quinn received the Uplifting Athletes Young Investigator award and has helped secure a $1.25 million NIH grant for CRB1 research.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

curing retinal blindness foundation competitors and assessment

Company assessment

Direct peers

  • Choroideremia Research Foundation: The Choroideremia Research Foundation funds research into a rare inherited retinal disorder and provides education, support, and community connections for affected families. It is a direct disease-specific peer to CRBF's CRB1 research-funding and family-support model.
  • Usher Syndrome Coalition: The Usher Syndrome Coalition is a patient-led nonprofit advancing research, education, and support for Usher syndrome, a rare genetic condition involving vision and hearing loss. Its patient-community and research-advocacy model closely parallels CRBF's.
  • The Vision of Children Foundation: The Vision of Children Foundation funds research and family support for children with genetic vision disorders. It is directly comparable in combining a rare genetic eye-disease mission, research grants, and affected-family support.

Broad incumbents

  • Foundation Fighting Blindness: Foundation Fighting Blindness is a larger nonprofit that funds research into inherited retinal diseases and supports patients and families. Its broader retinal-disease portfolio overlaps CRBF's mission and provides a relevant scale and operating-model benchmark.
  • Retina International: Retina International is a global umbrella organization representing people with retinal dystrophies and promoting research and access to care. It is comparable as a broader retinal-disease advocacy and research platform.
  • Fight for Sight: Fight for Sight is a UK-based charity that funds vision and eye research and mobilizes donors around sight loss. It is a relevant research-funder peer, although it is not focused specifically on CRB1 or operating a patient registry.
  • National Organization for Rare Disorders: The National Organization for Rare Disorders is a broad U.S. rare-disease organization that supports patient groups, research, and advocacy. CRBF's relationship and meetup plans with NORD make it an ecosystem-level peer despite its broader disease scope.
  • Global Genes: Global Genes is a rare-disease patient advocacy and education organization that connects patients, advocates, and industry. It is a broad ecosystem peer rather than a direct CRB1 competitor.

Regional players

  • Fighting Blindness Canada: Fighting Blindness Canada is a Canadian nonprofit supporting people affected by inherited retinal disease and funding vision research. It is a regional peer with similar patient education, advocacy, and research-funding activities.
  • Macular Disease Foundation Australia: Macular Disease Foundation Australia is a national patient organization providing macular-disease education, support, and research advocacy. It is a regional peer because it shares a disease-specific eye-support model but serves Australia.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

curing retinal blindness foundation social profiles

Digital presence

curing retinal blindness foundation compliance and trust

Trust signal

Compliance1 record

curing retinal blindness foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

curing retinal blindness foundation leadership team

Management profile

Number of profiles

Profiles1 record

curing retinal blindness foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

curing retinal blindness foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about curing retinal blindness foundation

What does curing retinal blindness foundation do?

CRBF is a 501(c)(3) nonprofit foundation that funds scientific research toward treatments and cures for CRB1 retinal disease (Leber's Congenital Amaurosis, Retinitis Pigmentosa, and cone-rod dystrophy). It maintains a CRB1 Patient Registry to support research efforts, connects affected families with resources for thriving with blindness, and runs awareness and fundraising campaigns including Eye on the Finish Line, Cars for the Cure, and Drive the Research.

Is curing retinal blindness foundation a public or private company?

curing retinal blindness foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was curing retinal blindness foundation founded?

curing retinal blindness foundation was founded in 2011. It employs 1 to 10 people.

Where is curing retinal blindness foundation based?

curing retinal blindness foundation is headquartered in Salem, United States, in the North America region.

How does curing retinal blindness foundation make money?

One revenue line is on record: donations and Fundraising.

Who are curing retinal blindness foundation's main competitors?

Direct peers on record are Choroideremia Research Foundation, Usher Syndrome Coalition and The Vision of Children Foundation. Broad incumbents are Foundation Fighting Blindness, Retina International, Fight for Sight, National Organization for Rare Disorders and Global Genes. Regional players are Fighting Blindness Canada and Macular Disease Foundation Australia.

Does curing retinal blindness foundation have an API?

No public API is recorded for curing retinal blindness foundation.

What industry is curing retinal blindness foundation in?

curing retinal blindness foundation's product category is Nonprofit Disease Advocacy Foundation. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease), with a secondary code of HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 541714.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales